The material contained on this Web site is provided for informational purposes only and does not constitute legal advice. The publication and receipt of any information contained on this Web site does not create an attorney-client relationship with Barash Law LLC or with any of our attorneys. Readers should not act upon any information on this site without seeking professional legal counsel. While the information on this Web site is maintained and periodically updated for accuracy, this information may contain omissions or errors for which we disclaim any and all liability.
Barash Law LLC does not collect identifying information from visitors to its Web site unless the information is provided by the visitor or the visitor's internet browser. We will only respond to direct inquiries, and will use information collected from internet browsers for the sole purpose of monitoring Web site usage. We do not share Web site data with outside third-parties. Barash Law LLC is not responsible for the privacy practices or content of any links to other Web sites contained in our Firm’s Web site.
If you have any questions or concerns regarding this Privacy Statement, please contact us at email@example.com
Eyal Barash will be joined by Debora Plehn-Dujowich of Eckert Seamans in a panel discussing key concepts related to both patentability and infringement of solid form patents on both the innovator and generic perspective and share their experiences in defending or attacking such patents.Register Here
Drug repurposing is often directed to developing new methods or formulations of pre-existing drug substances, often taking for granted the drug itself. As such, the focus of repurposing efforts is not directed to altering drug substance, especially in the small molecule context. However, by altering the solid-state properties of a drug substance, it is often possible to alter its delivery properties and, at the same time, create valuable new drug substance intellectual property. This presentation will discuss the strategy of deploying new small-molecule solid form drug substance patents for drug repurposing.Register Here
Eyal Barash will be hosting a CLE course in which he will dive into the World Trade Organization's TRIPS agreement regarding COVID-19 vaccines and treatments. This course will offer 2.0 hours of CLE credit for $100. Proceeds of this event will benefit the Jewish Federation of Lafayette.Registration Coming Soon